Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Israel Glucose Monitoring Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Product (Self-Monitoring Glucose Devices and Continuous Glucose Monitoring Devices)
5.2.2. By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)
5.2.3. By End User (Home Care Settings, Hospital, Others)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By Application
5.3.3. By End User
5.3.4. By Region
6. Israel Self-Monitoring Glucose Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application
6.2.2. By Component (Glucose Meter Devices, Glucose Test Strips, and Lancets)
6.2.3. By End User
7. Israel Continuous Glucose Monitoring Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application
7.2.2. By Component (Sensors, Transmitters & receivers, Integrated Insulin Pumps)
7.2.3. By End User
8. Market Dynamics
8.1. Drivers
8.2. Challenges
9. Market Trends & Developments
9.1. Recent Developments
9.2. Merger & Acquisition
9.3. Product Launches
10. Policy & Regulatory Landscape
11. Israel Economic Profile
12. Israel Glucose Monitoring Devices Market: SWOT Analysis
13. Competitive Landscape
13.1. Business Overview
13.2. Product Offerings
13.3. Recent Developments
13.4. Financials (As Reported)
13.5. Key Personnel
13.6. SWOT Analysis
13.6.1. Roche Israel
13.6.2. Abbott Diagnostics
13.6.3. MEDTRONIC ISRAEL LLC.
13.6.4. Johnson & Johnson
13.6.5. LifeScan Israel
13.6.6. Ascensia Diabetes Care
14. Strategic Recommendations